The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings von Mallat, A, Teixeira‐Clerc, F, Deveaux, V, Manin, S, Lotersztajn, S

Volltext

Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver von Mallat, A, Lotersztajn, S

Volltext

CB2 receptors as new therapeutic targets for liver diseases von Lotersztajn, S, Teixeira‐Clerc, F, Julien, B, Deveaux, V, Ichigotani, Y, Manin, S, Tran‐Van‐Nhieu, J, Karsak, M, Zimmer, A, Mallat, A

Volltext

Mucosal-associated invariant T cells are functionally impaired during chronic liver diseases and promote fibrosis von Hegde, P, Weiss, E, Wan, J, Paradis, V, Rautou, P.-E, Mabire, M, Ferrere, G, Gupta, A, Letteron, P, Kiaf, B, Toubal, A, Moreau, R, Lehuen, A, Lotersztajn, S

Volltext

Endocannabinoids and Their Role in Fatty Liver Disease von Mallat, A., Lotersztajn, S.

Volltext

P0426 : Inhibition of monoacylglycerol lipase accelerates liver fibrosis regression von Habib, A, Wan, J, Hedge, P, Weiss, E, Brouillet, A, Lodder, J, Moreau, R, Lotersztajn, S

Volltext

O037 : Macrophage autophagy mediated the beneficial effects of cannabinoid receptor 2 in alcoholic liver disease von Denaes, T, Lodder, J, Chobert, M.-N, Pawlotsky, J.-M, Lotersztajn, S, Teixeira-Clerc, F

Volltext

Endocannabinoids as novel mediators of liver diseases von Mallat, A, Lotersztajn, S

Volltext

Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis von Mallat, A, Lotersztajn, S

Volltext

377 INHIBITION OF THE PRO-FIBROGENIC TH17 IMMUNE RESPONSE BY CANNABINOID RECEPTOR 2 AGONIST DECREASES LIVER FIBROSIS von Lafdil, F, Guillot, A, Bizy, A, Zoltani, K, Deveaux, V, Zafrani, S, Mallat, A, Lotersztajn, S

Volltext

771 HEPATITIS C VIRUS ACTIVATES, BUT DOES NOT INFECT, HUMAN HEPATIC STELLATE CELLS/MYOFIBROBLASTS (HSC/MFS) IN PRIMARY CULTURE von Chouteau, P, Florimond, A, Mérour, E, Mallat, A, Lotersztajn, S, Pawlotsky, J.-M

Volltext

93 INTERLEUKIN-10 RELEASED BY M2 KUPFFER CELLS PROMOTES M1 KUPFFER CELL APOPTOSIS: A NOVEL PROTECTIVE MECHANISM AGAINST ALCOHOLIC LIVER DISEASE von Wan, J, Benkdane, M, Teixeira-Clerc, F, Deveaux, V, Louvet, A, Lafdil, F, Pecker, F, Mallat, A, Lotersztajn, S, Pavoine, C

Volltext

97 PROTECTIVE ROLE OF M2-POLARIZED KUPFFER CELLS AGAINST ALCOHOLIC LIVER DISEASE von Wan, J, Benkdane, M, Teixeira-Clerc, F, Deveaux, V, Louvet, A, Pecker, F, Mallat, A, Pavoine, C, Lotersztajn, S

Volltext

54 CANNABINOID RECEPTOR 2 PROTECTS AGAINST ALCOHOL-INDUCED STEATOSIS BY REGULATING KUPFFER CELL POLARIZATION von Teixeira-Clerc, F, Louvet, A, Chobert, M.-N, Deveaux, V, Zimmer, A, Mallat, A, Lotersztajn, S

Volltext

989 BENEFICIAL PARACRINE EFFECTS OF CANNABINOID CB2 RECEPTORS ON LIVER INJURY AND REGENERATION von Teixeira-Clerc, F, Belot, M.-P, Manin, S, Deveaux, V, Zimmer, A, Tordjmann, T, Mallat, A, Lotersztajn, S

Volltext

791 BENEFICIAL EFFECTS OF CANNABINOID RECEPTOR 2 ON ALCOHOLIC LIVER DISEASE von Louvet, A, Teixeira-Clerc, F, Deveaux, V, Chobert, M.-N, Pavoine, C, Mallat, A, Lotersztajn, S

Volltext

108 CANNABINOID CB2 RECEPTORS STIMULATE LIVER REGENERATION von Belot, M.-P, Teixeira-Clerc, F, Manin, S, Deveaux, V, van Nhieu, J. tran, Zimmer, A, Mallat, A, Lotersztajn, S

Volltext

Antifibrogenic role of the cannabinoid receptor CB2 in the liver von Julien, Boris, Grenard, Pascale, Teixeira-Clerc, Fatima, Van Nhieu, Jeanne Tran, Li, Liying, Karsak, Meliha, Zimmer, Andreas, Mallat, Ariane, Lotersztajn, Sophie

Volltext

789 ROLE OF THE AUTOPHAGY IN HEPATOCYTE DEATH IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): STUDY IN VITRO, IN MICE AND IN HUMANS von Lavallard, V, Bonnafous, S, Rousseau, D, Bailly-Maitre, B, Anty, R, Saint-Paul, M.-C, Sadoul, J.-L, Ianelli, A, Deveaux, V, Lotersztajn, S, Gounon, P, Gugenheim, J, Le Marchand-Brustel, Y, Tran, A, Gual, P

Volltext

Hepatic fibrosis: Molecular mechanisms and drug targets von LOTERSZTAJN, Sophie, JULIEN, Boris, TEIXEIRA-CLERC, Fatima, GRENARD, Pascale, MALLAT, Ariane

Volltext